Carlsmed
CARL
75 hedge funds and large institutions have $59.3M invested in Carlsmed in 2026 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 13 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 12
85% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 13
24% more capital invested
Capital invested by funds: $48M → $59.3M (+$11.4M)
14% more funds holding
Funds holding: 66 → 75 (+9)
1.2% more ownership
Funds ownership: 19.83% → 21.03% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Pier Capital
Stamford,
Connecticut
|
+$3.93M |
| 2 |
Millennium Management
New York
|
+$3.11M |
| 3 |
PWM
Palumbo Wealth Management
Great Neck,
New York
|
+$2.81M |
| 4 |
KC
KCM Capital
Shawnee,
Kansas
|
+$2.52M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$969K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$11.3M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$614K |
| 3 |
BGM
Burkehill Global Management
New York
|
-$453K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$393K |
| 5 |
WB
WesBanco Bank
Wheeling,
West Virginia
|
-$335K |
CARL Hedge Fund Activity: Q2 2026 in Review
75 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Carlsmed (CARL) for Q2 2026, worth a combined $59.3M — up 24% from $48M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CARL positions and 13 closed out — a net gain of 11 holders — while 32 added to existing stakes and 12 trimmed.
The largest buyer was Pier Capital, opening a new position worth an estimated $3.93M. The largest seller was OrbiMed, exiting entirely with an estimated $11.3M sold.
- 75 institutional investors held Carlsmed (CARL) as of Q2 2026, up from 66 in Q1 2026.
- Funds reported $59.3M of Carlsmed stock for Q2 2026, up 24% quarter-over-quarter.
- 24 funds opened new Carlsmed positions in Q2 2026 and 13 closed out, a net change of +11 holders.
- The largest Carlsmed buyer in Q2 2026 was Pier Capital, an estimated $3.93M added.
- The largest Carlsmed seller in Q2 2026 was OrbiMed, an estimated $11.3M sold.
Based on aggregated 13F filings for Q2 2026.